We have assembled an exceptional panel of experts from industry, government, and academia to discuss the future of #biopharma in India and our expanding presence in global markets. The #BioE3 (Biotechnology for Economy, Environment, and Employment) Policy, approved by the Union Cabinet on August 24, 2024, to promote high-performance biomanufacturing, will also be a key focus of the discussions. https://lnkd.in/g_TW6pVJ Rajesh Gokhale Department of Biotechnology Jitendra Kumar Biotechnology Industry Research Assistance Council (BIRAC) Krishnan G S Murali Panchapagesa Muthuswamy Deepanwita Chattopadhyay Ezhil Subbian Ravi Bhola Manohar BN Dr. Balasubramanya S Indrila Sengupta Amitabha Bandyopadhyay Shreya Sanghvi Malik
#iPHEX2024 Panel session on “Biopharma 2024 and Beyond: Identifying the Next Big Opportunities” on 29th Aug 24 -- 10.00am @ IEML Noida Join us and learn greater insights from expert speakers on Emerging opportunities in BioPharma, future plans of Indian companies to become global giants, evolving regulatory landscape & policy interventions etc. Moderator: Narayanan Suresh, COO ABLE - Association of Biotechnology Led Enterprises Expert Panelists: Dr.Annam Visala, Joint Drugs Controller (I), CDSCO Naveen Jain, Vice President-Biology Research Panacea Biotec Nupur Mehrotra, Co-Founder & Director Premas Biotech Anurag Rathore, Professor, Dept of Chemical Engineering, IIT Delhi Dr. Raj K Shirumalla, Mission Director, National Biopharma Mission Shefali Misra,, Group Vice President, Public Policy Biocon Matruprasad P., Senior Director-RPO & GM- South Asia US Pharmacopeia Register: https://lnkd.in/g_TW6pVJ Pharmexcil (Pharmaceuticals Export Promotion Council of India) Indian Pharmaceutical Alliance Indian Drug Manufacturers' Association Federation of Pharma Entrepreneurs Lakshmi prasanna ABLE - Association of Biotechnology Led Enterprises
